Sign in

You're signed outSign in or to get full access.

V

Ventas (VTR)·Q4 2025 Earnings Summary

Ventas Beats on Revenue and EBITDA, Raises Dividend 8% as Senior Housing Momentum Accelerates

February 6, 2026 · by Fintool AI Agent

Banner

Ventas (NYSE: VTR) delivered a strong Q4 2025, beating both revenue and EBITDA estimates while announcing an 8% dividend increase. The healthcare REIT's Senior Housing Operating Portfolio (SHOP) continues to drive outperformance, with same-store NOI up 15% year-over-year. The stock rose 2.7% to $79.84 following the results, approaching its 52-week high of $81.89.

Did Ventas Beat Earnings?

Yes — Ventas beat on both revenue and EBITDA.

MetricQ4 2025 ActualConsensusSurprise
Revenue$1,489M$1,436M+3.7%
EBITDA$586M$556M+5.5%
Normalized FFO/Share$0.89+10% YoY

The Q4 2025 Normalized FFO of $0.89 per share represented 10% year-over-year growth, capping a strong full year where Normalized FFO reached $3.48 per share (+9% YoY).

Total company Same-Store Cash NOI grew 8% year-over-year, led by the dominant SHOP segment which continues to benefit from favorable demographic tailwinds and constrained new supply.

FintoolAsk Fintool AI Agent

What Did Management Guide?

Ventas issued 2026 guidance that exceeded investor expectations, supported by continued SHOP momentum and an active investment pipeline.

2026 Outlook

Metric2026 Guidance2025 ActualYoY Change
Normalized FFO/Share$3.78 - $3.88$3.48*+8%
SHOP Same-Store NOI+13% to +17%+15%Continued strength
Total Co. Same-Store NOI+8.5% to +10.5%+8%Acceleration
Investments~$2.5B$2.5B (closed)In-line

*2025 FFO adjusted for methodology change (adding back stock-based compensation)

Key guidance assumptions include:

  • SHOP average occupancy growth of ~270bp
  • RevPOR (Revenue Per Occupied Room) growth of ~5%
  • SHOP revenue growth of ~8%
  • Operating expense growth of ~5% (maintaining operating leverage)
  • Interest expense of ~$636M at midpoint
  • FAD capital expenditures of ~$400M

Dividend Increase

The Board declared a quarterly dividend of $0.52 per share, representing an 8% increase from the prior $0.48, reflecting confidence in the company's cash flow growth trajectory.

How Did the Stock React?

VTR shares rose +2.7% to $79.84 on the earnings release, with aftermarket trading indicating further gains to $80.20.

The stock is now up approximately 36% from its 52-week low of $58.72 and sits just 2.5% below its 52-week high of $81.89. Year-to-date, VTR has outperformed broader REIT indices, benefiting from:

  1. Favorable demographics: The 80+ population is expected to grow 28% over the next 5 years
  2. Constrained supply: U.S. senior housing inventory growth at 0.5% YoY, near record lows
  3. Active M&A: $4.8B in U.S. senior housing acquisitions since October 2024

What Changed From Last Quarter?

SHOP Performance Continues to Accelerate

SHOP Segment Breakdown

The SHOP segment now represents 53% of total company NOI, up from 31% in Q4 2021—a 2,200bp increase in just four years.

SHOP MetricQ4 2025Q3 2025SequentialYoY
Same-Store Cash NOI ($M)$235.6$231.0+2.0%+15.4%
Average Occupancy90.1%89.0%+100bp+300bp
U.S. Occupancy+370bp
U.S. IL Occupancy+490bp
RevPOR Growth+4.7%

Key Q4 drivers:

  • Strong, broad-based demand that continued past the typical selling season
  • Ventas OIT™ (Operational Insights) platform outperforming NIC Top 99 by 160bp in cumulative occupancy growth since Q1 2023
  • 43 operators now on the Ventas platform, up from 10 in December 2020

Balance Sheet Strength

MetricQ4 2025Q3 2025
Net Debt / Further Adjusted EBITDA5.2x5.3x
Available Liquidity$5.3B
S&P / Moody's RatingBBB+ / Baa1Stable

The company repaid $500M of Q1 2026 debt maturities with proceeds from 5.0% 10-year Senior Notes issued in December 2025. Capital raised in 2025 totaled $7B across multiple sources, demonstrating strong access to capital markets.

FintoolAsk Fintool AI Agent

Segment Performance Summary

By Segment (Q4 2025 Same-Store Cash NOI Growth)

SegmentYoY Growth2026 Guidance
SHOP+15.4%+13% to +17%
Outpatient Medical & Research+3.7%+2% to +3%
Triple-Net-1.3%+3.75% to +4.75%
Total Company+7.8%+8.5% to +10.5%

Outpatient Medical Highlights

The Outpatient Medical & Research segment continues to provide stable cash flows:

  • 96% of properties affiliated with health systems or hospitals
  • Median health system credit rating of A+
  • 86% trailing twelve-month retention rate
  • 70% on-campus locations
  • 83% investment grade tenants

Investment Activity & External Growth

Ventas has been aggressively deploying capital into senior housing, closing $4.8 billion in U.S. senior housing acquisitions since October 2024.

Investment criteria focus on:

  • Right Market, Right Asset, Right Operator™
  • Double-digit to mid-teens unlevered IRR expectation
  • At or below replacement cost (~$324k per unit average)
  • Large-scale communities averaging 123 units
  • Markets with ~1,300bp uncapped net demand

The company has already closed $842M in senior housing investments through early February 2026, providing a fast start toward the $2.5B full-year target.

Total Addressable Market

The U.S. senior housing market represents a $450-600 billion opportunity. Ventas currently owns just 4% of the market by units, with private investors, owner-operators, and non-profits holding 86%.

What Did Management Say? (Key Quotes)

On Market Opportunity — CEO Debbie Cafaro emphasized the historic demographic inflection point:

"This year marks a historic demographic inflection point when baby boomers start to turn 80. This cohort of nearly 70 million individuals is the wealthiest generation ever... There were only about 2,500 new senior housing units started in the fourth quarter of 2025, while we expect over 2 million people to turn 80 in 2026."

On Competitive Positioning — President Justin Hutchens highlighted their acquisition advantages:

"Our pipeline is very active... When it comes to marketed deals, there is increased competition. What we're finding is, where we have our advantages, first of all, the track record of closing, which has caused repeat sellers to [bring] opportunities with us."

On Operating Leverage — Hutchens on margin expansion potential:

"It gets better the higher the occupancy goes, because the operating leverage kicks in. In 2026... we're expecting incremental margin in the 50s. And then we would expect that over time, as we move up the ladder toward 100%, higher incremental margin, usually around 70% or so."

On Future Supply — Asked about development, Hutchens explained:

"We think rents need to be 20%-30% higher, and that's even at a relatively modest development yield... The first [new supply] you would see announced in terms of starts would be ultra-premium products... a product that is so differentiated in terms of price when they enter a market."

Q&A Highlights

Brookdale Transitions — The 45 communities transitioned from triple-net to SHOP are positioned for long-term growth. Five experienced operators are now in place, with capital refresh projects underway and most expected to complete before key selling season (May-September). Management expects "modest NOI growth in 2026" with a target to "double NOI across this group" over time.

Acquisition Competition — While competition for senior housing assets has increased, half of the $800M closed year-to-date was off-market. Cap rates are "drifting down" with recent blended rates sub-7%, though management will continue reporting as deals close.

RevPOR Acceleration — In-house rent increases are running at 8% (vs 7% last year), driving RevPOR growth. A "rule of thumb" is that RevPOR runs at approximately two-thirds of in-house rent increases, putting it just under 5%. Move-in rents are also showing "solid underlying trends."

Flu Season Impact — Despite national headlines about an elevated flu season, management reported "minimal flu impacts" with "very few reports of any kind of outbreak" across the portfolio. Post-pandemic improvements in infection control, protective equipment, and visitor protocols have helped.

Independent Living Strength — The IL portfolio is driving outsized occupancy gains (490bp YoY in U.S.) as it's "more of a discretionary choice" with longer sales cycles. Ventas is roughly half-and-half by units between IL and AL and prefers the continuum-of-care mix when acquiring.

Canada Portfolio — Now just 16% of SHOP (down from 30% a few years ago) due to faster U.S. growth. The portfolio is "very high quality, high-performing" at 97% occupancy but "doesn't grow as much as the U.S."

FintoolAsk Fintool AI Agent

Risks and Concerns

While Q4 results were strong, investors should monitor:

  1. Interest Rate Sensitivity: Interest expense of ~$636M expected in 2026; further rate increases could pressure FFO

  2. Labor Costs: SHOP operating expense growth of ~5% guided for 2026, with labor market dynamics remaining a key variable

  3. Triple-Net Headwinds: The segment saw -1.3% same-store NOI decline in Q4, partially due to expiry of non-cash rental income from Brookdale lease

  4. Execution Risk on Investments: $2.5B investment target requires continued access to attractive acquisition opportunities at disciplined pricing

Forward Catalysts

Near-term (Next 1-2 quarters):

  • Continued SHOP occupancy gains as Baby Boomers begin turning 80 in 2026
  • Integration of recent acquisitions onto Ventas OIT™ platform
  • Q1 2026 results showing progress toward full-year guidance

Medium-term (2026):

  • Potential for guidance raises if SHOP momentum continues above midpoint
  • Additional acquisition announcements given $2.5B target
  • Further deleveraging toward Net Debt/EBITDA below 5.0x
FintoolAsk Fintool AI Agent

Key Takeaways

  1. Beat on top and bottom line: Revenue +3.7% vs consensus, EBITDA +5.5% vs consensus
  2. SHOP driving the story: 15% same-store NOI growth, 300bp occupancy gains, now 53% of total NOI
  3. 8% dividend increase: Signals management confidence in sustainable cash flow growth
  4. 2026 guidance solid: FFO growth of 8% at midpoint, continued double-digit SHOP NOI growth expected
  5. Balance sheet in good shape: 5.2x leverage, $5.3B liquidity, BBB+/Baa1 ratings

Data sourced from Ventas Q4 2025 earnings slides and Q4 2025 earnings call transcript . Financial data from S&P Global.

Related Links: